Literature DB >> 10180200

The importance of patient empowerment in health system reform.

L Segal1.   

Abstract

Health system reform is on the agenda in Australia, across Europe and North America and elsewhere. Reform is being driven by attempts to meet ever increasing health service demands in the face of cost containment pressures. There is little agreement concerning the preferred features of health funding models. A micro-economic framework is used to define universal performance characteristics for optimal health funding arrangements. Two principle requirements emerge. These are (1) demand side reform to empower consumers and (2) supply side reform, to promote opportunities and incentives for a responsive service system and competition amongst providers. A focus on supply side issues only, without recognition of the fundamental importance of consumer empowerment will fail to promote an efficient solution to the distribution of health resources. Mechanisms to promote active consumer involvement in health care decisions are identified as a central requirement in health system reform.

Entities:  

Mesh:

Year:  1998        PMID: 10180200     DOI: 10.1016/s0168-8510(98)00007-4

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  11 in total

1.  Pluralism, public choice, and the state in the emerging paradigm in health systems.

Authors:  Dov Chernichovsky
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

Review 2.  Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis.

Authors:  David Samoocha; David J Bruinvels; Nieke A Elbers; Johannes R Anema; Allard J van der Beek
Journal:  J Med Internet Res       Date:  2010-06-24       Impact factor: 5.428

3.  Positive correlation between the use of complementary and alternative medicine and internal health locus of control.

Authors:  Masa Sasagawa; Mark R Martzen; William J Kelleher; Cynthia A Wenner
Journal:  Explore (NY)       Date:  2008 Jan-Feb       Impact factor: 1.775

4.  Dealing with coronary artery disease in early encountering: a qualitative study.

Authors:  Mohammad Mojalli; Hossein Karimi Moonaghi; Shahla Khosravan; Ali Mohammadpure
Journal:  Int Cardiovasc Res J       Date:  2014-12-01

5.  Effectiveness of a Web-based tailored interactive health communication application for patients with type 2 diabetes or chronic low back pain: randomized controlled trial.

Authors:  Nina Weymann; Jörg Dirmaier; Alessa von Wolff; Levente Kriston; Martin Härter
Journal:  J Med Internet Res       Date:  2015-03-03       Impact factor: 5.428

6.  Patient empowerment, what does it mean for adults in the advanced stages of a life-limiting illness: A systematic review using critical interpretive synthesis.

Authors:  Dominique Wakefield; Jo Bayly; Lucy Ellen Selman; Alice M Firth; Irene J Higginson; Fliss Em Murtagh
Journal:  Palliat Med       Date:  2018-06-29       Impact factor: 4.762

7.  Market failure, policy failure and other distortions in chronic disease markets.

Authors:  Jennifer J Watts; Leonie Segal
Journal:  BMC Health Serv Res       Date:  2009-06-18       Impact factor: 2.655

8.  Regional primary care team to deliver best-practice diabetes care: a needs-driven health workforce model reflecting a biopsychosocial construct of health.

Authors:  Leonie Segal; Matthew J Leach; Esther May; Catherine Turnbull
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

9.  A nutrition strategy to reduce the burden of diet related disease: access to dietician services must complement population health approaches.

Authors:  Leonie Segal; Rachelle S Opie
Journal:  Front Pharmacol       Date:  2015-08-11       Impact factor: 5.810

10.  Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned.

Authors:  Tamiru S Degaga; Sophie Weston; Tedla T Tego; Dagimawie T Abate; Ashenafi Aseffa; Adugna Wayessa; Ric N Price; Asrat Hailu; Kamala Thriemer
Journal:  Malar J       Date:  2020-06-08       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.